(Q37139276)

18 August 2017

1 reference

title

Safety of drug-eluting stents (English)

1 reference

18 August 2017

1

Stephan Windecker

1 reference

18 August 2017

2

Peter Jüni

1 reference

18 August 2017

publication date

15 April 2008

1 reference

Nature Clinical Practice Cardiovascular Medicine

18 August 2017

published in

1 reference

18 August 2017

volume

5

1 reference

18 August 2017

issue

6

1 reference

18 August 2017

page(s)

316-328

1 reference

Long-term clinical follow-up in patients with angiographic restudy after successful angioplasty.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Coronary-artery stents

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Effectiveness and safety of drug-eluting stents in Ontario.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-1): a randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Acute coronary syndrome is a common clinical presentation of in-stent restenosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Bare metal stent restenosis is not a benign clinical entity.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up: A key determinant of survival in diabetics after coronary balloon angioplasty

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Local vascular dysfunction after coronary paclitaxel-eluting stent implantation.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Intravascular ultrasound in the drug-eluting stent era.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Very late thrombosis after drug-eluting stents

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Rapamycin, but not FK-506, increases endothelial tissue factor expression: implications for drug-eluting stent design

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Paclitaxel enhances thrombin-induced endothelial tissue factor expression via c-Jun terminal NH2 kinase activation.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Stent thrombosis in randomized clinical trials of drug-eluting stents

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Clinical end points in coronary stent trials: a case for standardized definitions

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Risk of thrombosis with the use of sirolimus-eluting stents for percutaneous coronary intervention (from registry and clinical trial data).

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Late stent thrombosis in the absence of prior intracoronary brachytherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Late coronary stent thrombosis: early vs. late stent thrombosis in the stent era

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

As time goes by: current status and future directions in the controversy over stenting

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Targeted stent use in clinical practice based on evidence from the Basel Stent Cost Effectiveness Trial (BASKET).

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Coronary artery stenting and non-cardiac surgery--a prospective outcome study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Prasugrel versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

1 reference

7 January 2021

Late stent thrombosis: considerations and practical advice for the use of drug-eluting stents: a report from the Society for Cardiovascular Angiography and Interventions Drug-eluting Stent Task Force

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1189

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO1189

1 reference

18 August 2017

1 reference